Rama Hritani, Aliza Hussain, Anum Saeed, Anandita Agarwala. Future Cardiol 2021
Times Cited: 2
Times Cited: 2
Times Cited
Times Co-cited
Similarity
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021.
. Diabetes Care 2021
. Diabetes Care 2021
50
Report from the 5th cardiovascular outcome trial (CVOT) summit.
Oliver Schnell, Eberhard Standl, Xavier Cos, Hiddo Jl Heerspink, Baruch Itzhak, Nebojsa Lalic, Michael Nauck, Antonio Ceriello. Cardiovasc Diabetol 2020
Oliver Schnell, Eberhard Standl, Xavier Cos, Hiddo Jl Heerspink, Baruch Itzhak, Nebojsa Lalic, Michael Nauck, Antonio Ceriello. Cardiovasc Diabetol 2020
50
Canagliflozin: metabolic, cardiovascular and renal protection.
Vivencio Barrios, Carlos Escobar. Future Cardiol 2021
Vivencio Barrios, Carlos Escobar. Future Cardiol 2021
50
Lessons learned from large Cardiovascular Outcome Trials targeting inflammation in cardiovascular disease (CANTOS, CIRT, COLCOT and LoDoCo2).
Michelle Samuel, Jean-Claude Tardif. Future Cardiol 2021
Michelle Samuel, Jean-Claude Tardif. Future Cardiol 2021
50
Shift of conventional paradigm of heart failure treatment: from angiotensin receptor neprilysin inhibitor to sodium-glucose co-transporter 2 inhibitors?
Alexander E Berezin, Alexander A Berezin. Future Cardiol 2021
Alexander E Berezin, Alexander A Berezin. Future Cardiol 2021
50
Glucagon-like peptide-1 receptor agonists and the cardiorenal axis in Type 2 diabetes: a focus on dulaglutide.
Richard J MacIsaac. Future Cardiol 2021
Richard J MacIsaac. Future Cardiol 2021
50
Metformin in the era of new antidiabetics.
Ez Alddin Rajjoub Al-Mahdi, Vivencio Barrios, Jose L Zamorano. Future Cardiol 2021
Ez Alddin Rajjoub Al-Mahdi, Vivencio Barrios, Jose L Zamorano. Future Cardiol 2021
100
100
Canakinumab for secondary prevention of coronary artery disease.
Luis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo. Future Cardiol 2021
Luis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo. Future Cardiol 2021
50
Cardiovascular outcome trials in Type 2 diabetes: food for thought.
Jadin J Chahade, Ryekjang Kim, John R Ussher. Future Cardiol 2021
Jadin J Chahade, Ryekjang Kim, John R Ussher. Future Cardiol 2021
100
Evaluation of dapagliflozin in the treatment of heart failure.
Sara Sotirakos. Future Cardiol 2021
Sara Sotirakos. Future Cardiol 2021
50
Cardiovascular disease prevention and therapy in women with Type 2 diabetes.
Camilla Cocchi, Francesca Coppi, Alberto Farinetti, Anna Vittoria Mattioli. Future Cardiol 2021
Camilla Cocchi, Francesca Coppi, Alberto Farinetti, Anna Vittoria Mattioli. Future Cardiol 2021
50
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.
William T Cefalu, Sanjay Kaul, Hertzel C Gerstein, Rury R Holman, Bernard Zinman, Jay S Skyler, Jennifer B Green, John B Buse, Silvio E Inzucchi, Lawrence A Leiter,[...]. Diabetes Care 2018
William T Cefalu, Sanjay Kaul, Hertzel C Gerstein, Rury R Holman, Bernard Zinman, Jay S Skyler, Jennifer B Green, John B Buse, Silvio E Inzucchi, Lawrence A Leiter,[...]. Diabetes Care 2018
50
Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease.
Johny Nicolas, Victor Razuk, Gennaro Giustino, Roxana Mehran. Future Cardiol 2021
Johny Nicolas, Victor Razuk, Gennaro Giustino, Roxana Mehran. Future Cardiol 2021
100
Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men.
N Faghihnia, L M Mangravite, S Chiu, N Bergeron, R M Krauss. Eur J Clin Nutr 2012
N Faghihnia, L M Mangravite, S Chiu, N Bergeron, R M Krauss. Eur J Clin Nutr 2012
50
VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.
Gaia Botteri, Marta Montori, Anna Gumà, Javier Pizarro, Lídia Cedó, Joan Carles Escolà-Gil, Diana Li, Emma Barroso, Xavier Palomer, Alison B Kohan,[...]. Diabetologia 2017
Gaia Botteri, Marta Montori, Anna Gumà, Javier Pizarro, Lídia Cedó, Joan Carles Escolà-Gil, Diana Li, Emma Barroso, Xavier Palomer, Alison B Kohan,[...]. Diabetologia 2017
50
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease.
Michal Pawlak, Philippe Lefebvre, Bart Staels. J Hepatol 2015
Michal Pawlak, Philippe Lefebvre, Bart Staels. J Hepatol 2015
50
Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.
Robert S Rosenson, David A Wolff, Anna L Huskin, Irene B Helenowski, Alfred W Rademaker. Diabetes Care 2007
Robert S Rosenson, David A Wolff, Anna L Huskin, Irene B Helenowski, Alfred W Rademaker. Diabetes Care 2007
50
Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia.
Ann C Skulas-Ray, Petar Alaupovic, Penny M Kris-Etherton, Sheila G West. J Clin Lipidol 2015
Ann C Skulas-Ray, Petar Alaupovic, Penny M Kris-Etherton, Sheila G West. J Clin Lipidol 2015
50
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial.
Hidenori Arai, Shizuya Yamashita, Koutaro Yokote, Eiichi Araki, Hideki Suganami, Shun Ishibashi. J Atheroscler Thromb 2018
Hidenori Arai, Shizuya Yamashita, Koutaro Yokote, Eiichi Araki, Hideki Suganami, Shun Ishibashi. J Atheroscler Thromb 2018
50
Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
J Auwerx, K Schoonjans, J C Fruchart, B Staels. J Atheroscler Thromb 1996
J Auwerx, K Schoonjans, J C Fruchart, B Staels. J Atheroscler Thromb 1996
50
Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination.
Shizuya Yamashita, Hidenori Arai, Koutaro Yokote, Eiichi Araki, Mitsunori Matsushita, Toshiaki Nojima, Hideki Suganami, Shun Ishibashi. Int J Mol Sci 2019
Shizuya Yamashita, Hidenori Arai, Koutaro Yokote, Eiichi Araki, Mitsunori Matsushita, Toshiaki Nojima, Hideki Suganami, Shun Ishibashi. Int J Mol Sci 2019
50
ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity.
Mengdie Luo, Aiying Liu, Shuai Wang, Tianle Wang, Die Hu, Sha Wu, Daoquan Peng. Sci Rep 2017
Mengdie Luo, Aiying Liu, Shuai Wang, Tianle Wang, Die Hu, Sha Wu, Daoquan Peng. Sci Rep 2017
50
Association of apolipoprotein-CIII (apoC-III), endothelium-dependent vasodilation and peripheral neuropathy in a multi-ethnic population with type 2 diabetes.
Sharon Li Ting Pek, Chee Fang Sum, Lee Ying Yeoh, Simon Biing Ming Lee, Wern Ee Tang, Su Chi Lim, Subramaniam Tavintharan. Metabolism 2017
Sharon Li Ting Pek, Chee Fang Sum, Lee Ying Yeoh, Simon Biing Ming Lee, Wern Ee Tang, Su Chi Lim, Subramaniam Tavintharan. Metabolism 2017
50
Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.
Jan Oscarsson, Kristina Önnerhag, Ulf Risérus, Mattias Sundén, Lars Johansson, Per-Anders Jansson, Linda Moris, Peter M Nilsson, Jan W Eriksson, Lars Lind. J Clin Lipidol 2018
Jan Oscarsson, Kristina Önnerhag, Ulf Risérus, Mattias Sundén, Lars Johansson, Per-Anders Jansson, Linda Moris, Peter M Nilsson, Jan W Eriksson, Lars Lind. J Clin Lipidol 2018
50
MicroRNA-424-5p regulates aortic smooth muscle cell function in atherosclerosis by blocking APOC3-mediated nuclear factor-κB signalling pathway.
Chuanfang Li, Meng Zhang, Yuchuan Dai, Zesheng Xu. Exp Physiol 2020
Chuanfang Li, Meng Zhang, Yuchuan Dai, Zesheng Xu. Exp Physiol 2020
50
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.
Jan Borén, Chris J Packard, Marja-Riitta Taskinen. Front Endocrinol (Lausanne) 2020
Jan Borén, Chris J Packard, Marja-Riitta Taskinen. Front Endocrinol (Lausanne) 2020
50
Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials.
Amirhossein Sahebkar, Luis E Simental-Mendía, Dimitri P Mikhailidis, Matteo Pirro, Maciej Banach, Cesare R Sirtori, Massimiliano Ruscica, Željko Reiner. J Clin Lipidol 2018
Amirhossein Sahebkar, Luis E Simental-Mendía, Dimitri P Mikhailidis, Matteo Pirro, Maciej Banach, Cesare R Sirtori, Massimiliano Ruscica, Željko Reiner. J Clin Lipidol 2018
50
Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin-resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction.
Oliviero Olivieri, Nicola Martinelli, Marco Sandri, Antonella Bassi, Patrizia Guarini, Elisabetta Trabetti, Francesca Pizzolo, Domenico Girelli, Simonetta Friso, Pier Franco Pignatti,[...]. Clin Chem 2005
Oliviero Olivieri, Nicola Martinelli, Marco Sandri, Antonella Bassi, Patrizia Guarini, Elisabetta Trabetti, Francesca Pizzolo, Domenico Girelli, Simonetta Friso, Pier Franco Pignatti,[...]. Clin Chem 2005
50
A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients.
Jogchum Plat, Gemma Brufau, Geesje M Dallinga-Thie, Margreet Dasselaar, Ronald P Mensink. J Nutr 2009
Jogchum Plat, Gemma Brufau, Geesje M Dallinga-Thie, Margreet Dasselaar, Ronald P Mensink. J Nutr 2009
50
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Marja-Riitta Taskinen, Jan Borén. Curr Atheroscler Rep 2016
Marja-Riitta Taskinen, Jan Borén. Curr Atheroscler Rep 2016
50
Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes.
Karin Åvall, Yusuf Ali, Ingo B Leibiger, Barbara Leibiger, Tilo Moede, Meike Paschen, Andrea Dicker, Elisabetta Daré, Martin Köhler, Erwin Ilegems,[...]. Proc Natl Acad Sci U S A 2015
Karin Åvall, Yusuf Ali, Ingo B Leibiger, Barbara Leibiger, Tilo Moede, Meike Paschen, Andrea Dicker, Elisabetta Daré, Martin Köhler, Erwin Ilegems,[...]. Proc Natl Acad Sci U S A 2015
50
ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
Kyriakos E Kypreos. Biochemistry 2008
Kyriakos E Kypreos. Biochemistry 2008
50
Apoprotein C-III: A review of its clinical implications.
Jing-Lu Jin, Yuan-Lin Guo, Jian-Jun Li. Clin Chim Acta 2016
Jing-Lu Jin, Yuan-Lin Guo, Jian-Jun Li. Clin Chim Acta 2016
50
Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials.
Amirhossein Sahebkar, Luis E Simental-Mendía, Niki Katsiki, Željko Reiner, Maciej Banach, Matteo Pirro, Stephen L Atkin. BMJ Open 2019
Amirhossein Sahebkar, Luis E Simental-Mendía, Niki Katsiki, Željko Reiner, Maciej Banach, Matteo Pirro, Stephen L Atkin. BMJ Open 2019
50
Reducing residual cardiovascular risk with novel therapies.
Michael H Davidson. Curr Opin Lipidol 2020
Michael H Davidson. Curr Opin Lipidol 2020
50
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia.
Björn W Karlson, Michael K Palmer, Stephen J Nicholls, Pia Lundman, Philip J Barter. Am J Cardiol 2016
Björn W Karlson, Michael K Palmer, Stephen J Nicholls, Pia Lundman, Philip J Barter. Am J Cardiol 2016
50
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII.
Oliviero Olivieri, Manuel Cappellari, Gianni Turcato, Bruno Bonetti, Domenico Girelli, Francesca Pizzolo, Simonetta Friso, Antonella Bassi, Annalisa Castagna, Nicola Martinelli. Stroke 2020
Oliviero Olivieri, Manuel Cappellari, Gianni Turcato, Bruno Bonetti, Domenico Girelli, Francesca Pizzolo, Simonetta Friso, Antonella Bassi, Annalisa Castagna, Nicola Martinelli. Stroke 2020
50
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation.
Stephen Zewinger, Jochen Reiser, Vera Jankowski, Dalia Alansary, Eunsil Hahm, Sarah Triem, Mira Klug, Stefan J Schunk, David Schmit, Rafael Kramann,[...]. Nat Immunol 2020
Stephen Zewinger, Jochen Reiser, Vera Jankowski, Dalia Alansary, Eunsil Hahm, Sarah Triem, Mira Klug, Stefan J Schunk, David Schmit, Rafael Kramann,[...]. Nat Immunol 2020
50
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation.
Ron C Hoogeveen, Christie M Ballantyne. Clin Chem 2021
Ron C Hoogeveen, Christie M Ballantyne. Clin Chem 2021
50
Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.
Mark J Graham, Richard G Lee, Thomas A Bell, Wuxia Fu, Adam E Mullick, Veronica J Alexander, Walter Singleton, Nick Viney, Richard Geary, John Su,[...]. Circ Res 2013
Mark J Graham, Richard G Lee, Thomas A Bell, Wuxia Fu, Adam E Mullick, Veronica J Alexander, Walter Singleton, Nick Viney, Richard Geary, John Su,[...]. Circ Res 2013
50
APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137 895 Individuals.
Anders B Wulff, Børge G Nordestgaard, Anne Tybjærg-Hansen. Arterioscler Thromb Vasc Biol 2018
Anders B Wulff, Børge G Nordestgaard, Anne Tybjærg-Hansen. Arterioscler Thromb Vasc Biol 2018
50
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes.
Andres Digenio, Richard L Dunbar, Veronica J Alexander, Marcus Hompesch, Linda Morrow, Richard G Lee, Mark J Graham, Steven G Hughes, Rosie Yu, Walter Singleton,[...]. Diabetes Care 2016
Andres Digenio, Richard L Dunbar, Veronica J Alexander, Marcus Hompesch, Linda Morrow, Richard G Lee, Mark J Graham, Steven G Hughes, Rosie Yu, Walter Singleton,[...]. Diabetes Care 2016
50
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation.
Nicola Martinelli, Marcello Baroni, Annalisa Castagna, Barbara Lunghi, Filippo Stefanoni, Federica Tosi, Jacopo Croce, Silvia Udali, Barry Woodhams, Domenico Girelli,[...]. Thromb Haemost 2019
Nicola Martinelli, Marcello Baroni, Annalisa Castagna, Barbara Lunghi, Filippo Stefanoni, Federica Tosi, Jacopo Croce, Silvia Udali, Barry Woodhams, Domenico Girelli,[...]. Thromb Haemost 2019
50
Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice.
Han Yingchun, Ma Yahong, Wen Jiangping, He Xiaokui, Zhang Xiaohong. Lipids Health Dis 2018
Han Yingchun, Ma Yahong, Wen Jiangping, He Xiaokui, Zhang Xiaohong. Lipids Health Dis 2018
50
Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.
Alison B Kohan. Curr Opin Endocrinol Diabetes Obes 2015
Alison B Kohan. Curr Opin Endocrinol Diabetes Obes 2015
50
Key differences between apoC-III regulation and expression in intestine and liver.
Gabrielle West, Cayla Rodia, Diana Li, Zania Johnson, Hongli Dong, Alison B Kohan. Biochem Biophys Res Commun 2017
Gabrielle West, Cayla Rodia, Diana Li, Zania Johnson, Hongli Dong, Alison B Kohan. Biochem Biophys Res Commun 2017
50
Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.
Hui-Young Lee, Andreas L Birkenfeld, Francois R Jornayvaz, Michael J Jurczak, Shoichi Kanda, Violeta Popov, David W Frederick, Dongyan Zhang, Blas Guigni, Kalyani G Bharadwaj,[...]. Hepatology 2011
Hui-Young Lee, Andreas L Birkenfeld, Francois R Jornayvaz, Michael J Jurczak, Shoichi Kanda, Violeta Popov, David W Frederick, Dongyan Zhang, Blas Guigni, Kalyani G Bharadwaj,[...]. Hepatology 2011
50
The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia.
Frank M Sacks. Curr Opin Lipidol 2015
Frank M Sacks. Curr Opin Lipidol 2015
50
Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.
Anna Helgadottir, Solveig Gretarsdottir, Gudmar Thorleifsson, Eirikur Hjartarson, Asgeir Sigurdsson, Audur Magnusdottir, Aslaug Jonasdottir, Helgi Kristjansson, Patrick Sulem, Asmundur Oddsson,[...]. Nat Genet 2016
Anna Helgadottir, Solveig Gretarsdottir, Gudmar Thorleifsson, Eirikur Hjartarson, Asgeir Sigurdsson, Audur Magnusdottir, Aslaug Jonasdottir, Helgi Kristjansson, Patrick Sulem, Asmundur Oddsson,[...]. Nat Genet 2016
50
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.